SAGE RHINO CAPITAL, LLC

Company

Vincerx Pharma, Inc.

Filed

August 4, 2021

Accession Number

0001085146-21-002223

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →